Search
SI-109
go.drugbank.com/drugs/DB32603ExperimentalSI-109 is a potent, small-molecule inhibitor of the STAT3 SH2 domain.[A275443]
GLB-001
go.drugbank.com/drugs/DB32795InvestigationalGLB-001 is a orally bioavailable molecular glue degrader targeting casein kinase 1 alpha (CK1a).[L56124, L56125, L56126]
Lys-plasminogen
go.drugbank.com/drugs/DB32870ExperimentalLys-plasminogen is a truncated form of natural human plasminogen.
Zolimomab aritox
go.drugbank.com/drugs/DB33667ExperimentalSynonyms: Xoma zyme h 65, Orthozyme cd 5 plusCategories: N-Glycosyl Hydrolases, Ribosome Inactivating Proteins, Type 2ONCOLYSIN B
go.drugbank.com/drugs/DB33671ExperimentalCategories: N-Glycosyl Hydrolases, Ribosome Inactivating Proteins, Type 2Synonyms: ONCOLYSIN BLm-LLO-TT
go.drugbank.com/drugs/DB33966ExperimentalLm-LLO-TT is a biologic drug. Lm-LLO-TT is under investigation in clinical trial NCT07828236 (PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA).
SRN-101
go.drugbank.com/drugs/DB33962ExperimentalSRN-101 is a biologic drug. … SRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.).
SGX-001
go.drugbank.com/drugs/DB33968ExperimentalSGX-001 is a biologic drug. SGX-001 is under investigation in clinical trial NCT07826767 (Open-label Gene Therapy Study in p47-CGD).
BI 4060107
go.drugbank.com/drugs/DB33963ExperimentalBI 4060107 is a small molecule drug. … BI 4060107 is under investigation in clinical trial NCT07827144 (A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)).
161Tb-PSMA-1
go.drugbank.com/drugs/DB33964Experimental161Tb-PSMA-1 is a small molecule drug. 161Tb-PSMA-1 is under investigation in clinical trial NCT07828249 (Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal